- Home
- TLSA vs FCO Comparison
TLSA vs FCO Comparison
Compare TLSA & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- FCO
- Stock Information
- Founded
- TLSA 2013
- FCO 1991
- Country
- TLSA United Kingdom
- FCO United Kingdom
- Employees
- TLSA N/A
- FCO N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- FCO Investment Managers
- Sector
- TLSA Health Care
- FCO Finance
- Exchange
- TLSA Nasdaq
- FCO Nasdaq
- Market Cap
- TLSA 187.0M
- FCO 85.6M
- IPO Year
- TLSA 2000
- FCO N/A
- Fundamental
- Price
- TLSA $1.48
- FCO $6.46
- Analyst Decision
- TLSA
- FCO
- Analyst Count
- TLSA 0
- FCO 0
- Target Price
- TLSA N/A
- FCO N/A
- AVG Volume (30 Days)
- TLSA 186.3K
- FCO 100.1K
- Earning Date
- TLSA 07-29-2025
- FCO 01-01-0001
- Dividend Yield
- TLSA N/A
- FCO 14.96%
- EPS Growth
- TLSA N/A
- FCO N/A
- EPS
- TLSA N/A
- FCO 0.43
- Revenue
- TLSA N/A
- FCO N/A
- Revenue This Year
- TLSA N/A
- FCO N/A
- Revenue Next Year
- TLSA N/A
- FCO N/A
- P/E Ratio
- TLSA N/A
- FCO $12.30
- Revenue Growth
- TLSA N/A
- FCO N/A
- 52 Week Low
- TLSA $0.63
- FCO $4.73
- 52 Week High
- TLSA $1.91
- FCO $6.63
- Technical
- Relative Strength Index (RSI)
- TLSA 50.51
- FCO 49.76
- Support Level
- TLSA $1.43
- FCO $6.34
- Resistance Level
- TLSA $1.54
- FCO $6.62
- Average True Range (ATR)
- TLSA 0.07
- FCO 0.09
- MACD
- TLSA -0.01
- FCO -0.01
- Stochastic Oscillator
- TLSA 47.22
- FCO 21.43
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.